This is why the medical weight loss route must never be walked alone
In no way should any QSR overcorrect and pivot fully into the GLP-1 craze they should simply realize that GLP-1 users are a new segment of the population that must be understood and to whom marketing dollars should be allocated
In a 6-month, randomized, double-masked, placebo-controlled study, ruboxistaurin enhanced skin microvascular blood flow at the distal calf, reduced sensory symptoms, improved the quality of life, and was well tolerated in DPN patients
PB serves on the advisory board of XORTX
Cant wait for week 4 #glp1 #glp1community #weightloss #weightlossjouney #fyp From 330 Pounds to 146: My GLP-1 Journey a As a registered nurse, Ive always been passionate about health and wellnessbut for a long time, I struggled to prioritize my own
From a public health perspective, these disparities have far-reaching implications